Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 9%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is well positioned for durable fundamental upside because its behavioral health segment, which generates just over half of consolidated operating income and over 55% of pretax profits, offers stronger margins and better growth economics than acute care. The company also benefits from solid operating momentum, with 1Q26 consolidated adjusted EBITDA up 8.4% year over year, behavioral health revenue up 7.3%, and pricing strength in both acute and behavioral services, while capacity expansion and new sites should support further volume recovery. In addition, a roughly $75 million pretax HIX headwind, potential Florida SDP upside, and an $800–900 million share repurchase program create multiple pathways for margin expansion, capital returns, and long-term value creation.

Bears say

Universal Health Services is viewed negatively because its earnings power appears vulnerable to multiple pressure points at once: management highlighted volume and margin headwinds, and the downside case assumes FY27 earnings about 5% below estimates alongside a ~4.75x multiple, consistent with trough levels seen in 2024. The company also faces structural risks from heavy concentration in Las Vegas, Nevada, Texas, and California, plus outsized exposure to behavioral health, which contributes over 55% of pretax profits and is more exposed to tight state budgets and reimbursement pressure than its >55% revenue acute care business. Added to that are regulatory uncertainty around Medicare-For-All or ACA repeal, clinical labor shortages that can compress margins, and a September 2020 cyberattack that caused a $67MM pre-tax impact.

UHS has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 11 analysts, UHS has a Buy consensus rating as of Oct 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $196.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $196.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.